← Back to Patent Explorer
US4291012A Expired / Lapsed US ⏱️ 0.0 years remaining

Technetium-labelled diagnostic agent for the examination of the RES

Assignee: Hoechst AG
•
Filing: 1979-01-04
•
Granted: 1981-09-22
•
Expires: 1999-01-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process is disclosed for the preparation of a diagnositc agent for scanning the RES, in particular the liver, by mixing the sodium salt of 1-phenyl-2,3-dimethyl-pyrazolone-4-methylamino-methylsulfonic acid or 1-phenyl-2,3-dimethyl-pyrazolone in aqueous solution with tin(II) salt, adjusting the solution to a pH between 4 and 9, optionally lyophilizing the mixture and adding 99m Tc-pertechnetate in physiological saline solution.

Inventors

  • 👤 Helmut Strecker
  • 👤 Michael Molter
  • 👤 Gerhard Kloss
  • 👤 Eberhard Schickel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 17:19
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/025; A61K51/04; A61K2123/00

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 70 words
A process for the preparation of a diagnostic agent for scanning the RES, which comprises mixing the sodium salt of 1-phenyl-2,3-dimethyl-pyrazolone-4-methylamino-methylsulfonic acid or 1-phenyl-2,3-dimethyl-pyrazolone in an aqueous solution with tin(II) salt in a molar ratio of 15:1 to 110:1, adjusting the resulting solution to a pH between 4 and 9, and afterwards adding from 0.1 to 100 mCi of 99m Tc-pertechnetate in 1 to 10 ml of physiological saline solution.
Claim 2
Dependent Claim 70 words
A process for the preparation of a diagnostic agent for scanning the RES, which comprises mixing the sodium salt of 1-phenyl-2,3-dimethyl-pyrazolone-4-methylamino-methylsulfonic acid or 1-phenyl-2,3-dimethyl-pyrazolone in an aqueous solution with tin(II) salt in a molar ratio of 15:1 to 110:1, adjusting the resulting solution to a pH between 4 and 9, and afterwards adding from 0.1 to 100 mCi of 99m Tc-pertechnetate in 1 to 10 ml of physiological saline solution.
Claim 3
Dependent Claim 26 words
The process as defined in claim 1 wherein the pH adjusted mixture of sodium salt of 1-phenyl-2,3-dimethyl-pyrazolone-4-methylamino-methylsulfonic acid and 1-phenyl-2,3-dimethyl-pyrazolone with tin(II) salt is further lyophilized.
Claim 4
Dependent Claim 25 words
A process as defined in claim 8 wherein the concentration of 1-phenyl-2,3-dimethyl-pyrazolone-4-methylaminomethylsulfonic acid or 1-phenyl-2,3-dimethyl-pyrazolone is in the range of from 0.1 to 200 mg/ml.
Claim 5
Dependent Claim 27 words
A process as claimed in claim 1 or 3 wherein the concentration of 1-phenyl-2,3-dimethyl-pyrazolone-4-methylamino-methylsulfonic acid or 1-phenyl-2,3-dimethyl-pyrazolone is in the range of from 1 to 50 mg/ml.
Claim 6
Dependent Claim 51 words
A process as claimed in claim 1 or 3 which comprises reacting a mixture consisting essentially from 1 to 50 mg of 1-phenyl-2,3-dimethyl-pyrazolone-4-methylaminomethylsulfonic acid or 1-phenyl-2,3-dimethyl-pyrazolone and from 0.02 to 1 mg of SnCl 2 .2 H 2 O with 88m Tc-pertechnetate in 1 to 10 ml of physiological saline solution.
Claim 7
Dependent Claim 23 words
A process as claimed in claim 1 or 3 wherein 1-phenyl-2,3-dimethyl-pyrazolone-4-methylamino-methylsulfonic acid or 1-phenyl-2,3-dimethyl-pyrazolone-tin- 99m Tc compounds are in a physiological saline solution.
Claim 8
Dependent Claim 27 words
A diagnostic agent for visualizing the RES consisting essentially of a colloidal 1-phenyl-2,3-dimethyl-pyrazolone-4-methylamino-methylsulfonic acid-tin(II) 99m Tc compound or colloidal 1-phenyl-2,3-dimethyl-pyrazolone-tin(II) 99m Tc compound in physiologically saline solution.
Claim 9
Dependent Claim 27 words
A diagnostic agent for visualizing the RES consisting essentially of a colloidal 1-phenyl-2,3-dimethyl-pyrazolone-4-methylamino-methylsulfonic acid-tin(II) 99m Tc compound or colloidal 1-phenyl-2,3-dimethyl-pyrazolone-tin(II) 99m Tc compound in physiologically saline solution.

References Cited (Backward Citations)

US3743713A Cited
US4087516A Cited
US4066742A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-09-21 1985-03-23 1985-09-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-09-21 1989-03-23 1989-09-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-09-21 1993-03-23 1993-09-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag